Prevalence of outpatient cancer treatment in the United States: Estimates from the Medical Panel Expenditures Survey (MEPS)

Michael T. Halpern, K. Robin Yabroff

Research output: Contribution to journalArticlepeer-review

38 Scopus citations

Abstract

Little is known regarding the prevalence of outpatient cancer treatment in the U.S. We analyzed nationally-representative data from the 2000-2004 Medical Expenditure Panel Survey to estimate the number of U.S. cancer patients receiving outpatient chemotherapy and/or radiation therapy annually. Each year, over 1.1 million individuals are estimated to receive chemotherapy or radiation therapy for cancer. Cancer patients younger than 65 receiving treatment who were uninsured were less likely to receive chemotherapy or combined chemotherapy/radiation therapy than were those with public or private insurance. These estimates may be useful for understanding the burden of cancer care and development of programs for cancer survivors.

Original languageEnglish (US)
Pages (from-to)647-651
Number of pages5
JournalCancer Investigation
Volume26
Issue number6
DOIs
StatePublished - Jul 2008

Keywords

  • MEPS
  • Outpatient
  • Treatment

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Prevalence of outpatient cancer treatment in the United States: Estimates from the Medical Panel Expenditures Survey (MEPS)'. Together they form a unique fingerprint.

Cite this